Alex Kopp

2.8k total citations · 1 hit paper
27 papers, 2.0k citations indexed

About

Alex Kopp is a scholar working on Cardiology and Cardiovascular Medicine, General Health Professions and Pharmacology. According to data from OpenAlex, Alex Kopp has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in General Health Professions and 5 papers in Pharmacology. Recurrent topics in Alex Kopp's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Gastroesophageal reflux and treatments (3 papers). Alex Kopp is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Gastroesophageal reflux and treatments (3 papers). Alex Kopp collaborates with scholars based in Canada, United Kingdom and United States. Alex Kopp's co-authors include David N. Juurlink, Muhammad Mamdani, Peter C. Austin, Gary Naglie, Paula A. Rochon, Andreas Laupacis, Irfan A. Dhalla, Tara Gomes, David Henry and Paul E. Szmitko and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Alex Kopp

26 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

2009 527 citations David N. Juurlink, Tara Gomes et al. Canadian Medical Association Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Kopp Canada	15	778	755	406	340	238	27	2.0k
Jacques LeLorier Canada	30	864 1.1×	529 0.7×	915 2.3×	157 0.5×	103 0.4×	95	3.3k
Joan‐Ramon Laporte Spain	26	310 0.4×	632 0.8×	334 0.8×	112 0.3×	99 0.4×	86	2.0k
L.A. García Rodríguez Spain	10	340 0.4×	760 1.0×	480 1.2×	100 0.3×	438 1.8×	16	1.8k
Consuelo Huerta Spain	22	361 0.5×	423 0.6×	553 1.4×	125 0.4×	69 0.3×	66	2.3k
Theresa Anderson United States	14	207 0.3×	1.2k 1.6×	231 0.6×	362 1.1×	41 0.2×	23	3.5k
Caroline Samer Switzerland	28	406 0.5×	283 0.4×	199 0.5×	128 0.4×	31 0.1×	107	2.5k
Nuria Riera‐Guàrdia United States	12	233 0.3×	522 0.7×	285 0.7×	84 0.2×	60 0.3×	14	1.4k
Charles E. Leonard United States	26	516 0.7×	156 0.2×	320 0.8×	185 0.5×	55 0.2×	127	2.3k
Marilisa Franceschi Italy	35	337 0.4×	382 0.5×	1.5k 3.6×	94 0.3×	798 3.4×	94	3.3k
Rikke Sørensen Denmark	27	2.3k 3.0×	490 0.6×	650 1.6×	123 0.4×	64 0.3×	91	3.9k

Countries citing papers authored by Alex Kopp

Since Specialization

Citations

This map shows the geographic impact of Alex Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Kopp more than expected).

Fields of papers citing papers by Alex Kopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Kopp. The network helps show where Alex Kopp may publish in the future.

Co-authorship network of co-authors of Alex Kopp

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Kopp. A scholar is included among the top collaborators of Alex Kopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Kopp. Alex Kopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vahabi, Mandana, Aïsha Lofters, Jennifer Rayner, et al.. (2024). Silent Voices of Immigrants and Refugees Battling with Mental Health and Addiction during COVID-19: A Follow- Up Population-Based Cohort Retrospective Study in Ontario, Canada. 8(3).

Kiran, Tara, Michael Green, Lidija Latifovic, et al.. (2023). Relational Continuity, Physician Payment, and Team-Based Primary Care in the Canadian Health Care System. The Journal of the American Board of Family Medicine. 36(1). 130–141. 3 indexed citations

Rayner, Jennifer, et al.. (2020). Nurse Practitioner Activities in Ontario Family Health Teams Comparing Three Different Data Sources. Nursing leadership. 33(2). 67–79. 1 indexed citations

Tomlinson, George, J. Michael Paterson, Vandana Ahluwalia, et al.. (2019). Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage. JAMA Network Open. 2(12). e1917053–e1917053. 19 indexed citations

Glazier, Richard H., Michael Green, Eliot Frymire, et al.. (2019). Do Incentive Payments Reward The Wrong Providers? A Study Of Primary Care Reform In Ontario, Canada. Health Affairs. 38(4). 624–632. 25 indexed citations

Macdonald, Erin M., Anna Chu, Ruth Croxford, et al.. (2018). Development of a Concept Dictionary to Standardize Definitions and Classifications While Working With a Common Repository of Linked Administrative Data. International Journal for Population Data Science. 3(4). 1 indexed citations

Zinman, Lorne, et al.. (2009). Safety of influenza vaccination in patients with myasthenia gravis: A population‐based study. Muscle & Nerve. 40(6). 947–951. 33 indexed citations

Juurlink, David N., Tara Gomes, Dennis T. Ko, et al.. (2009). A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. Canadian Medical Association Journal. 180(7). 713–718. 527 indexed citations breakdown →

Dhalla, Irfan A., Muhammad Mamdani, Marco L.A. Sivilotti, et al.. (2009). Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Canadian Medical Association Journal. 181(12). 891–896. 336 indexed citations

10.

Kopp, Alex, et al.. (2006). Proton Pump Inhibitors and Hospitalization for Clostridium Difficile--Associated Disease: A Population-Based Study. Clinical Infectious Diseases. 43(10). 1272–1276. 120 indexed citations

11.

Mamdani, Muhammad, Lauren Klein Warren, Alex Kopp, et al.. (2006). Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario. Canadian Medical Association Journal. 175(12). 1535–1538. 17 indexed citations

12.

Tu, Karen, Muhammad Mamdani, Alex Kopp, & Douglas S. Lee. (2005). Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure. The American Journal of Cardiology. 95(2). 283–286. 15 indexed citations

13.

Stroud, Lynfa, Muhammad Mamdani, Alex Kopp, & Chaim M. Bell. (2005). The safety of levofloxacin in elderly patients on warfarin. The American Journal of Medicine. 118(12). 1417.e7–1417.e12. 15 indexed citations

14.

Mamdani, Muhammad, David N. Juurlink, Alex Kopp, et al.. (2004). Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. BMJ. 328(7453). 1415–1416. 75 indexed citations

15.

Mamdani, Muhammad, David N. Juurlink, Douglas S. Lee, et al.. (2004). Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. The Lancet. 363(9423). 1751–1756. 327 indexed citations

16.

Mamdani, Muhammad, Paula A. Rochon, David N. Juurlink, et al.. (2003). Effect of Selective Cyclooxygenase 2 Inhibitors and Naproxen on Short-term Risk of Acute Myocardial Infarction in the Elderly. Archives of Internal Medicine. 163(4). 481–481. 210 indexed citations

17.

Mamdani, Muhammad, Paula A. Rochon, David N. Juurlink, et al.. (2002). Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ. 325(7365). 624.1–624.1. 211 indexed citations

18.

Hoerauf, Klaus, Tilo Hartmann, Alex Kopp, et al.. (2001). Waste gas exposure to sevoflurane and nitrous oxide during anaesthesia using the oesophageal–tracheal Combitube small adultTM. British Journal of Anaesthesia. 86(1). 124–126. 15 indexed citations

19.

Kopp, Alex, et al.. (2000). Effect of pre-emptive hydromorphone administration on postoperative pain relief--a randomized controlled trial.. PubMed. 112(23). 1002–6. 2 indexed citations

20.

Fischer, Peter, Alex Kopp, & Elena Massarotti. (1996). Anaerobic Septic Bursitis: Case Report and Review. Clinical Infectious Diseases. 22(5). 879–879. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact